Vivira

What Vivira does

Vivira Health Lab GmbH, founded in 2015 in Munich and Berlin, develops ViViRA — a prescription digital therapeutic (DiGA) for musculoskeletal conditions, primarily back pain, with additional coverage of knee and hip pain. The core product is a mobile application (iOS and Android) that delivers four personalized daily exercises targeting mobility, stability, and coordination, with weekly progress protocols, monthly movement tests, and adaptive intensity adjustment based on user feedback on pain and difficulty. The app is CE-marked as a Class I medical device under EU MDR 2017/745, permanently listed in the BfArM DiGA directory, and certified to ISO 13485 (quality) and ISO 27001 (information security) — a combination Vivira claims to be the first to achieve among German DiGA manufacturers.

The business model is dual-track: (1) prescription-driven reimbursement, where physicians prescribe ViViRA and patients submit prescriptions to statutory health insurers (all GKV and most private insurers cover it), receiving a 16-digit activation code, with pricing set by the German arbitration body; and (2) direct-to-consumer self-pay subscription at €69/month with a 7-day free trial. Vivira also operates a complimentary prescription submission service that handles reimbursement paperwork on behalf of patients, plus a dedicated healthcare professional portal (Fachkreise) for physician engagement. Distribution combines app store product-led growth with a prescription channel through the German DiGA framework.

The company has trained 200,000+ users, holds category leadership as the most prescribed DiGA for musculoskeletal disorders in Germany (per BARMER Doctor Report 2024), and was founded by Dr. Philip Heimann (current Managing Director) alongside rehabilitation clinic operators Dr. Petra Becker and Fabian Blank. In May 2026, Vivira closed a growth financing round led by IBB Capital and Bonventure, with stated use of funds for therapy portfolio expansion, deeper AI integration, and international expansion beyond Germany. The company employs 11–50 staff.

Name

Vivira

Legal name

Vivira Health Lab GmbH

Website

https://vivira.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Digital Therapeutics (Musculoskeletal)

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industry

Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home (HSABADAN)

Keywords

• Digital therapeutic app
• Musculoskeletal rehabilitation
• Prescription health application
• Digital health software
• Back pain treatment

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Health Insurance Reimbursement: German statutory health insurers (GKV) cover ViViRA costs with physician prescription. All statutory health insurers and most private insurers reimburse. Patients submit prescription or diagnostic proof to their insurer, which provides a 16-digit activation code. The German arbitration body sets the official price.
2. Direct Consumer Subscription: Self-paying customers can subscribe for EUR 69.00 per month with automatic monthly renewal. 7-day free trial available. Subscription can be cancelled 24 hours before renewal in app stores.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

Vivira develops and sells ViViRA, a prescription digital therapeutic (DiGA) mobile application that delivers daily personalized exercise programs for patients with musculoskeletal pain, primarily back pain. The product functions as an alternative or supplement to physiotherapy, with reimbursement by German statutory health insurers when prescribed by a physician, or via a self-pay subscription at EUR 69 per month.

Product overview

Vivira Health Lab GmbH offers ViViRA as its primary product, a Digital Health Application (DiGA) for musculoskeletal conditions. The core offering is the ViViRA mobile app, which provides guided therapeutic exercise programs for back pain. The product portfolio includes the main app distributed via iOS and Android platforms, a prescription service (Rezept-Service) that helps patients submit e-prescriptions to health insurers, a help center for user support, and a dedicated portal for healthcare professionals. The app is prescribed by physicians and reimbursed by statutory health insurance in Germany, or available via self-pay subscription at €69/month.

Differentiator

Problem solved

Functional benefit

Products and services

• ViViRA (Digital Therapeutic App) A prescription digital therapeutic application (DiGA) for musculoskeletal conditions, providing guided daily therapeutic exercise programs for back, knee, and hip pain. Delivers four daily exercises targeting mobility, stability, and coordination, adapts to user feedback, tracks progress via weekly protocols and monthly movement tests, and is CE-certified as a Class I medical device for adult patients with musculoskeletal disorders in Germany.

Quantifiable outcome

• 53% average pain reduction over 12 weeks compared to 15% for conventional physiotherapy
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature4 records

Partnerships

One partnership is on record.

• CMX Remote GmbHminorImplementation/ SI/ Consulting PartnerService center partner handling inbound/outbound calls, faxes, and emails for customer and prospect communications.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• SWORD Health: Digital MSK therapy combining an app with connected hardware, sold primarily to employers and health plans. Competes for the same patient population and clinician-prescribed digital therapy budgets as Vivira.
• Caspar Health: Berlin-based digital rehabilitation platform combining tele-rehab with prescribed therapeutic exercises for MSK and neurological conditions. Direct peer in German digital rehab, often reimbursed by German payers.
• Kaia Health: Digital therapeutic for musculoskeletal pain (back, knee, hip) delivered via mobile app, with both B2C and B2B channels. Direct competitor in the MSK digital therapeutics category where Vivira competes, including overlap in the German DTx market.
• Selfapy: Berlin-based digital therapeutics company offering DiGA-listed apps (mental health, etc.) via the same German reimbursement framework as Vivira. Same DiGA go-to-market and regulatory model; competes for physician prescribing share and insurer mindshare.

Emerging players

• Temedica: Munich-based digital health company building condition-specific companion apps and real-world evidence platforms. Comparable in being a Munich-based health-software company pursuing regulated digital health products in Germany.
• Sidekick Health: Nordic digital therapeutics company addressing chronic conditions (cardio-metabolic, MSK adjacent) via app-based care. Comparable in business model (prescription/sponsor-funded DTx) and category ambition.
• Perfood: German digital therapeutics company (e.g., sinCephalea migraine DiGA) operating under the same DiGA framework as Vivira. Competes for BfArM-listed DTx status and statutory health insurer reimbursement.

Broad incumbents

• Hinge Health: Largest US-based digital MSK care provider offering app-based exercise therapy, often with wearable sensors, sold to employers and payers. Competes for MSK digital therapy demand globally and increasingly in Europe.

Regional players

• Wellster Healthtech Group: Munich-based digital health platform offering tele-medicine and prescription digital health products to German consumers. Comparable as a German digital health distribution and care-delivery platform.
• Oviva: Europe-based digital therapeutic for diet-related and metabolic conditions (including DiGA-listed products in Germany) sold to insurers and patients. Comparable as a European DTx scaling through reimbursed, app-based care pathways.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/vivirahealth
• LinkedInlinkedin.com/company/vivirahealth
• Xx.com/vivirahealth

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivira